Caricamento...
The Impact of Body Mass Index Upon the Efficacy of Adalimumab in Hidradenitis Suppurativa
Elevated BMI in Hidradenitis Suppurativa is associated with decreased response to Adalimumab therapy. BMI is proposed to segregate distinct disease subtypes. It remains unresolved whether a threshold BMI exists above which increased dosages may provide clinical benefit. Individual patient data from...
Salvato in:
| Pubblicato in: | Front Med (Lausanne) |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8257943/ https://ncbi.nlm.nih.gov/pubmed/34239882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.603281 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|